• Home
  • About OliX

About OliX

Management

Management

  • Dong Ki Lee, Ph.D.

    CEO

    • Ph.D. in Biochemistry, Cornell University
    • Professor, Sungkyunkwan University
  • Shin Young Park, Ph.D.

    Executive Vice President / Development Dept.

    • Ph.D. in Pharmacy, Seoul Nat’l University
    • Korea Institute of Toxicology (KIT)
    • Diplomate of American Board of Toxicologist (DABT)
  • Chung Gil Kang

    Vice President / Management Dept.

    • M.S. in Management Science, KAIST
    • Kumho Asiana Group, Powerlogics
    • L&S Venture Capital
  • Young Hye Baek

    Executive Director / Legal Affairs

    • B.S & M.S in Biology, KAIST
    • Patent lawyer
  • June Hyun Park, Ph.D.

    Director / Research Dept.

    • B.S. in Biochemistry, Oregon State University
    • Ph.D. in Biochemistry, Seoul Nat’l University
    • Principal Scientist, Samsung Bioepis
  • Young Jin Kim

    Director / Finance Dept.

    • B.S in Social Science, Hanyang University
    • KPMG Samjong, PWC Samil
    • Korea Institute of Certified Public Accountants (KICPA)

Scientific Advisory Board

John Lis Professor, Cornell University
Member of National Academy of Sciences
Platform Technology
Demetrios G. Vavvas Associate Professor of Ophthalmology at HARVARD Medical School
Co-Director at Massachusetts Eye & Ear Infirmary (MEEI)
Monte J Wallace Ophthalmology Chair in Retina
Ophthalmology
Hyewon Chung Professor, Konkuk University Ophthalmology
Yury V. Popov Associate Professor of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School Hepatology
Gordon Jiang Transplant hepatologist and physician-scientist at Beth Israel Deaconess Medical Center, Harvard Medical School Hepatology
Aaron Hakim Clinical Fellow in Medicine (EXT) Beth Israel Deaconess Medical Center, Harvard Medical School Hepatology